DEĞERTEKIN, Bülent et al. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience. Turkish Journal of Gastroenterology, [S. l.], v. 31, n. 12, p. 883–893, 2020. DOI: 10.5152/tjg.2020.20696. Disponível em: https://turkjgastroenterol.org/index.php/tjg/article/view/3664. Acesso em: 1 jan. 2026.